目的 探讨益气温阳补肾方加减治疗老年高血压脾肾阳虚证的临床效果。方法 选取2021年12月—2022年11月期间青岛市中医医院收治的脾肾阳虚证老年高血压患者98例,采用随机数字表法分为对照组和试验组,每组各49例。对照组给予常规西药降压...目的 探讨益气温阳补肾方加减治疗老年高血压脾肾阳虚证的临床效果。方法 选取2021年12月—2022年11月期间青岛市中医医院收治的脾肾阳虚证老年高血压患者98例,采用随机数字表法分为对照组和试验组,每组各49例。对照组给予常规西药降压治疗,试验组在对照组基础上联合益气温阳补肾方加减治疗,两组患者均治疗4周。观察比较两组患者临床疗效、治疗安全性,治疗前后中医证候积分、血压[收缩压(Systolic blood pressure,SBP)、舒张压(Diastolic blood pressure,DBP)、脉压(Pulse pressure,PP)、24 h SBP、24 h DBP]水平、血管内皮功能指标[内皮素-1(Endothelin-1,ET-1)、一氧化氮(Nitric oxide,NO)、血栓素A2(Thrombin A2,TXA_(2))]水平。结果 (1)临床疗效:治疗后试验组总有效率95.92%(47/49)明显高于对照组81.25%(39/48),差异有统计学意义(P<0.05)。(2)中医证候积分:治疗后两组患者中医证候各项症状积分均较治疗前降低,差异有统计学意义(P<0.05);且试验组中医证候各项症状积分均明显低于对照组,差异有统计学意义(P<0.05)。(3)血压监测水平:治疗后两组患者SBP、DBP、PP、24 h SBP、24 h DBP水平均较治疗前降低,差异有统计学意义(P<0.05);且试验组SBP、DBP、PP、24 h SBP、24 h DBP水平均明显低于对照组,差异有统计学意义(P<0.05)。(4)血管内皮功能水平:治疗后两组患者血清ET-1、TXA_(2)均较治疗前降低,NO较治疗前升高,差异有统计学意义(P<0.05);且试验组ET-1、TXA_(2)均明显低于对照组,NO明显高于对照组,差异有统计学意义(P<0.05)。(5)安全性:治疗期间,两组患者均未发生严重或影响治疗的不良反应,仅对照组出现1例轻度潮红,未给予干预自行缓解。结论 益气温阳补肾方加减治疗老年高血压脾肾阳虚证效果显著,安全性高,有利于控制患者血压水平,且可能与调节血管内皮功能有关。展开更多
OBJECTIVES:To analyze the distribution characteristics of Traditional Chinese Medicine(TCM)syndromes in patients with oxaliplatin-induced peripheral neuropathy(OIPN)and observe the clinical efficacy of Bushen Yiqi for...OBJECTIVES:To analyze the distribution characteristics of Traditional Chinese Medicine(TCM)syndromes in patients with oxaliplatin-induced peripheral neuropathy(OIPN)and observe the clinical efficacy of Bushen Yiqi formula(补肾益气方,BSYQF)in treating patients with OIPN.METHODS:A total of 89 patients with OIPN were enrolled in this study.The TCM syndrome characteristics were investigated by frequency analysis methodology after collecting and analyzing the TCM syndrome elements of the patients with the OIPN TCM syndrome element scale.Further,62 cases of cold-dampness obstruction syndrome and kidney-Qi deficiency and cold syndrome were selected and randomly divided into the control group(n=31)and the treatment group(n=31).The patients in the treatment group were treated with modified BSYQF,while those in the control group were treated with mecobalamin tablets for 3 weeks.The Levi sensory neurotoxicity score and the neuro-electrophysiological changes were observed before and after the treatment in both groups.RESULTS:The distribution of TCM syndrome types in 89 patients with OIPN were in order of kidney-Qi deficiency and cold syndrome(44 cases),cold-dampness obstruction syndrome(18 cases),Yin deficiency of liver and kidney syndrome(11 cases),blood stasis obstruction syndrome(7 cases),and dampness-heat obstruction syndrome(5 cases).Improvement in Levi sensory neurotoxicity score:After 3-week treatment,the total effective rate in the treatment group was higher than that in the control group(P<0.05).The subgroup analysis showed that the total effective rate in the treatment group of patients with kidney-Qi deficiency and cold syndrome was higher than that in the control group before and after treatment(P<0.05).Improvement in nerve conduction velocity:The sensory nerve conduction velocity of bilateral ulnar nerves improved in the control group after treatment compared with that before treatment(P<0.05).The sensory and motor nerve conduction velocities of the bilateral ulnar and bilateral peroneal nerves improved in the treatment group compared with those before treatment and after treatment in the control group(P<0.05).CONCLUSIONS:The modified BSYQF had a definite therapeutic effect on the OIPN in patients with kidney-Qi deficiency and cold syndrome and those with cold-dampness obstruction syndrome.It could effectively reduce the grade of peripheral nerve toxicity and improve nerve conduction velocity,and its curative effect was better than that of mecobalamin tablets.展开更多
文摘目的 探讨益气温阳补肾方加减治疗老年高血压脾肾阳虚证的临床效果。方法 选取2021年12月—2022年11月期间青岛市中医医院收治的脾肾阳虚证老年高血压患者98例,采用随机数字表法分为对照组和试验组,每组各49例。对照组给予常规西药降压治疗,试验组在对照组基础上联合益气温阳补肾方加减治疗,两组患者均治疗4周。观察比较两组患者临床疗效、治疗安全性,治疗前后中医证候积分、血压[收缩压(Systolic blood pressure,SBP)、舒张压(Diastolic blood pressure,DBP)、脉压(Pulse pressure,PP)、24 h SBP、24 h DBP]水平、血管内皮功能指标[内皮素-1(Endothelin-1,ET-1)、一氧化氮(Nitric oxide,NO)、血栓素A2(Thrombin A2,TXA_(2))]水平。结果 (1)临床疗效:治疗后试验组总有效率95.92%(47/49)明显高于对照组81.25%(39/48),差异有统计学意义(P<0.05)。(2)中医证候积分:治疗后两组患者中医证候各项症状积分均较治疗前降低,差异有统计学意义(P<0.05);且试验组中医证候各项症状积分均明显低于对照组,差异有统计学意义(P<0.05)。(3)血压监测水平:治疗后两组患者SBP、DBP、PP、24 h SBP、24 h DBP水平均较治疗前降低,差异有统计学意义(P<0.05);且试验组SBP、DBP、PP、24 h SBP、24 h DBP水平均明显低于对照组,差异有统计学意义(P<0.05)。(4)血管内皮功能水平:治疗后两组患者血清ET-1、TXA_(2)均较治疗前降低,NO较治疗前升高,差异有统计学意义(P<0.05);且试验组ET-1、TXA_(2)均明显低于对照组,NO明显高于对照组,差异有统计学意义(P<0.05)。(5)安全性:治疗期间,两组患者均未发生严重或影响治疗的不良反应,仅对照组出现1例轻度潮红,未给予干预自行缓解。结论 益气温阳补肾方加减治疗老年高血压脾肾阳虚证效果显著,安全性高,有利于控制患者血压水平,且可能与调节血管内皮功能有关。
基金the Innovative Research Team of High-Level Local University in Shanghaithe Discipline Construction and Talent Training Project in Qingpu District of Shanghai:the Fourth Round of Key Discipline Construction in Qingpu District (No.WZ2019-04)+1 种基金the Fourth Round of Discipline Leader Training Plan in Qingpu District (WD2019-17/39 and WT-2019-02)the Project of Qingpu District Science and Technology Committee:Study on the Mechanism of Icariin Regulating GR in the Treatment of OIPN (No.QKY2020-34)
文摘OBJECTIVES:To analyze the distribution characteristics of Traditional Chinese Medicine(TCM)syndromes in patients with oxaliplatin-induced peripheral neuropathy(OIPN)and observe the clinical efficacy of Bushen Yiqi formula(补肾益气方,BSYQF)in treating patients with OIPN.METHODS:A total of 89 patients with OIPN were enrolled in this study.The TCM syndrome characteristics were investigated by frequency analysis methodology after collecting and analyzing the TCM syndrome elements of the patients with the OIPN TCM syndrome element scale.Further,62 cases of cold-dampness obstruction syndrome and kidney-Qi deficiency and cold syndrome were selected and randomly divided into the control group(n=31)and the treatment group(n=31).The patients in the treatment group were treated with modified BSYQF,while those in the control group were treated with mecobalamin tablets for 3 weeks.The Levi sensory neurotoxicity score and the neuro-electrophysiological changes were observed before and after the treatment in both groups.RESULTS:The distribution of TCM syndrome types in 89 patients with OIPN were in order of kidney-Qi deficiency and cold syndrome(44 cases),cold-dampness obstruction syndrome(18 cases),Yin deficiency of liver and kidney syndrome(11 cases),blood stasis obstruction syndrome(7 cases),and dampness-heat obstruction syndrome(5 cases).Improvement in Levi sensory neurotoxicity score:After 3-week treatment,the total effective rate in the treatment group was higher than that in the control group(P<0.05).The subgroup analysis showed that the total effective rate in the treatment group of patients with kidney-Qi deficiency and cold syndrome was higher than that in the control group before and after treatment(P<0.05).Improvement in nerve conduction velocity:The sensory nerve conduction velocity of bilateral ulnar nerves improved in the control group after treatment compared with that before treatment(P<0.05).The sensory and motor nerve conduction velocities of the bilateral ulnar and bilateral peroneal nerves improved in the treatment group compared with those before treatment and after treatment in the control group(P<0.05).CONCLUSIONS:The modified BSYQF had a definite therapeutic effect on the OIPN in patients with kidney-Qi deficiency and cold syndrome and those with cold-dampness obstruction syndrome.It could effectively reduce the grade of peripheral nerve toxicity and improve nerve conduction velocity,and its curative effect was better than that of mecobalamin tablets.